A New Chemical Entity (NCE) minus 1 filing, also known as a paragraph IV filing, is a type of application submitted to the U.S. Food and Drug Administration (FDA) for a new drug that represents a slight modification of an existing approved drug. The term "minus 1" indicates that the NCE is only one small…
